Associations of anemia and hemoglobin with hemoglobin A1c among non-diabetic workers in Japan.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
May 2020
Historique:
received: 04 07 2019
revised: 11 09 2019
accepted: 09 10 2019
pubmed: 13 10 2019
medline: 18 2 2021
entrez: 13 10 2019
Statut: ppublish

Résumé

We examined the association between hemoglobin A1c (HbA1c) and anemia, which was categorized into three groups according to mean corpuscular volume (MCV), as well as the association between hemoglobin in the non-anemic range and HbA1c. We used the 2016 health checkup data from 36,422 workers without diabetes. Anemic people were divided into three groups based on MCV: <80, 80-90 and >90 fL. Non-anemic people were divided into four groups based on their hemoglobin levels. We carried out multiple linear regression models to estimate the means and 95% confidence intervals (CIs) of HbA1c. For men, 0.2% had anemia with MCV <80 fL, 0.5% had anemia with MCV 80-90 fL, 0.9% had anemia with MCV >90 fL and 98.4% had no anemia. For women, the corresponding values were 6.1, 6.4, 2.8 and 84.7%, respectively. The adjusted mean HbA1c (%) values for men with anemia with MCV <80, 80-90 and >90 fL were 5.67 (95% CI 5.60-5.74), 5.58 (95% CI 5.54-5.62) and 5.41 (95% CI 5.37-5.44), respectively. Among men without anemia, HbA1c (%) increased from 5.36 (95% CI 5.34-5.39) in those with hemoglobin ≥17.5 mg/dL to 5.45 (95% CI 5.45-5.46) in those with hemoglobin 13.0 to <14.5 mg/dL (P for trend <0.001). The HbA1c values were higher in men with anemia with MCV <80 fL or MCV 80-90 fL, but lower in men with MCV >90 fL, compared with non-anemic men with hemoglobin 13.0 to <14.5 mg/dL (All P < 0.001). Similar findings were observed in women. We observed elevated HbA1c among anemic people with MCV <80 fL or MCV 80-90 fL, and decreased HbA1c among anemic people with MCV >90 fL, suggesting that different types of anemia might influence HbA1c differently. In addition, non-anemic people with lower hemoglobin levels had higher HbA1c levels, suggesting that hemoglobin levels are in need of consideration when interpreting HbA1c values among non-anemic people.

Identifiants

pubmed: 31605656
doi: 10.1111/jdi.13159
pmc: PMC7232301
doi:

Substances chimiques

Glycated Hemoglobin A 0
Hemoglobins 0
hemoglobin A1c protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

719-725

Subventions

Organisme : Industrial Health Foundation, Industrial Disease Clinical Research Grants
ID : 140202-01, 150903-01, 170301-01
Organisme : Japan Society for the Promotion of Science KAKENHI
ID : 16H05251
Organisme : National Center for Global Health and Medicine
ID : 28-Shi-1206

Informations de copyright

© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

J Diabetes. 2011 Mar;3(1):67-73
pubmed: 20942846
Eur J Intern Med. 2016 Dec;36:32-35
pubmed: 27594416
Indian J Hum Genet. 2011 Sep;17(3):115-6
pubmed: 22345979
J Intern Med. 1990 Feb;227(2):133-6
pubmed: 2299304
Medicine (Baltimore). 2015 May;94(20):e825
pubmed: 25997055
J Diabetes Investig. 2014 Feb 12;5(1):60-5
pubmed: 24843738
Diabetes Metab Syndr. 2013 Apr-Jun;7(2):118-22
pubmed: 23680254
Prim Care Diabetes. 2019 Aug;13(4):316-323
pubmed: 30718167
Prev Med. 2017 Mar;96:118-123
pubmed: 28040517
J Clin Epidemiol. 1993 Nov;46(11):1257-66
pubmed: 8229103
J Intern Med. 2013 Mar;273(3):283-93
pubmed: 23121487
Int J Behav Nutr Phys Act. 2015 Sep 18;12:119
pubmed: 26384967
J Gen Fam Med. 2017 Apr 13;18(5):200-204
pubmed: 29264027
Rinsho Ketsueki. 2015 Jul;56(7):752-9
pubmed: 26251137
Eur J Epidemiol. 2006;21(7):493-9
pubmed: 16858617
PLoS One. 2016 Nov 28;11(11):e0167210
pubmed: 27893805
J Diabetes Sci Technol. 2009 May 01;3(3):446-51
pubmed: 20144281
J Nutr. 2015 Mar;145(3):541-6
pubmed: 25733470
Nutrients. 2019 Jun 28;11(7):
pubmed: 31261779
J Clin Pathol. 1962 Jul;15:346-9
pubmed: 13920205
Blood. 1960 May;15:791-806
pubmed: 13841823
Clin Chem. 1998 Sep;44(9):1951-8
pubmed: 9732983
Diabetologia. 2015 Jul;58(7):1409-21
pubmed: 25994072
Diabetes Care. 2012 Apr;35(4):797-802
pubmed: 22323413
BMC Public Health. 2016 Mar 03;16:220
pubmed: 26939609
Clin Chem Lab Med. 2015 Nov;53(12):1883-94
pubmed: 26536581

Auteurs

Nobuaki Sakamoto (N)

Health Design Inc., Tokyo, Japan.

Huanhuan Hu (H)

Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.

Akiko Nanri (A)

Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Department of Food and Health Sciences, International College of Arts and Sciences, Fukuoka Women's University, Fukuoka, Japan.

Tetsuya Mizoue (T)

Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.

Masafumi Eguchi (M)

Furukawa Electric Co., Ltd., Tokyo, Japan.

Takeshi Kochi (T)

Furukawa Electric Co., Ltd., Tokyo, Japan.

Tohru Nakagawa (T)

Hitachi, Ltd., Ibaraki, Japan.

Toru Honda (T)

Hitachi, Ltd., Ibaraki, Japan.

Shuichiro Yamamoto (S)

Hitachi, Ltd., Ibaraki, Japan.

Takayuki Ogasawara (T)

Mitsubishi Fuso Truck and Bus Corporation, Kanagawa, Japan.

Naoko Sasaki (N)

Mitsubishi Fuso Truck and Bus Corporation, Kanagawa, Japan.

Akiko Nishihara (A)

Azbil Corporation, Tokyo, Japan.

Teppei Imai (T)

Azbil Corporation, Tokyo, Japan.

Toshiaki Miyamoto (T)

Nippon Steel Corporation Kimitsu Works, Chiba, Japan.

Makoto Yamamoto (M)

Yamaha Corporation, Shizuoka, Japan.

Hiroko Okazaki (H)

Mitsui Chemicals, Inc., Tokyo, Japan.

Kentaro Tomita (K)

Mitsubishi Plastics, Inc., Tokyo, Japan.

Akihiko Uehara (A)

Seijinkai Shizunai Hospital, Hokkaido, Japan.

Ai Hori (A)

Department of Global Public Health, University of Tsukuba, Ibaraki, Japan.

Makiko Shimizu (M)

Mizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan.

Taizo Murakami (T)

Mizue Medical Clinic, Keihin Occupational Health Center, Kanagawa, Japan.

Keisuke Kuwahara (K)

Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.
Teikyo University Graduate School of Public Health, Tokyo, Japan.

Ami Fukunaga (A)

Department of Epidemiology and Prevention, National Center for Global Health and Medicine, Tokyo, Japan.

Isamu Kabe (I)

Furukawa Electric Co., Ltd., Tokyo, Japan.

Tomofumi Sone (T)

National Institute of Public Health, Saitama, Japan.

Seitaro Dohi (S)

Mitsui Chemicals, Inc., Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH